Drug Index


Mechanism :

Budesonide is an anti-inflammatory corticosteroid that exhibits potent glucocorticoid activity and weak mineralocorticoid activity.

Indication :

  • Bronchial asthma
  • Bronchopulmonary dysplasia
  • Croup
  • Allergic rhinitis

Contraindications :

Contraindicated as the primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required. Hypersensitivity to budesonide or any of the ingredients of this preparation, compromised liver function and acute pulmonary tuberculosis are contraindications.

Dosing :

0.5 mg inhaled OD or divided into two doses daily. Maximum dose: 1 mg/day. Rinse mouth after use.
Inhalational powder/MDI:
Available as 100/200 mcg MDI/Rotacap
<6 years of age: Safety and efficacy not established.
>6 years of age: 100-200 mcg inhaled twice daily. In some patients may start at 400 mcg twice a day, do not exceed 400 mcg twice daily.
Allergic rhinitis:
Intranasal (Available as either 100 mcg or 32 mcg)
One spray for nostril every day (64 mcg/day).
6-11 years: Max: 2 sprays per nostril.
>12 years: Max: 4 sprays per nostril.
Mild to moderate Crohn's disease involving the ileum and/or ascending colon (Active disease):
Children >8 years and weight >25 kg: 9 mg PO OD in the morning for up to 8 weeks, followed by 6 mg PO OD for 2 weeks. If the patient was previously taking prednisolone, do not abruptly discontinue prednisolone; taper it down with the initiation of budes

Adverse Effect :

Mild irritation in the throat and hoarseness, respiratory infection, oral candidiasis, With intranasal administration: epistaxis, pharyngitis, nasal irritation.

Interaction :

Inhaled doses result in very low plasma levels; hence no drug interactions have been noted.

Renal Dose :

Dose in Renal Impairment GFR (mL/min)
20-50Dose as in normal renal function
10-20Dose as in normal renal function
<10Dose as in normal renal function

Dose in Patients undergoing Renal Replacement Therapies
CAPDUnlikely to be dialysed. Dose as in normal renal function
HDUnlikely to be dialysed. Dose as in normal renal function
HDF/High fluxUnlikely to be dialysed. Dose as in normal renal function
CAV/VVHDUnlikely to be dialysed. Dose as in normal renal function

Hepatic Dose :

Inhaled budesonide: No dosage adjustments are recommended.
Oral budesonide: Use a reduced dose of 3 mg OD in moderate hepatic impairment. Use is contraindicated in severe hepatic impairment.
02/19/2024 22:45:18 Budesonide
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0